Advanced Cancer Therapies
Intelligence Hub
Your starting point for independent research on CAR-T, TIL, NK Cell, and Gamma Delta T-cell therapies. Compare mechanisms, costs, and access — then explore each therapy in depth.
💡 The Reality Check: A lower price tag in advanced cellular therapy does not mean lower quality. In countries like China, costs are 70-90% lower due to government price negotiations and high patient volume in trials, not compromised safety. All partner centers are strictly NMPA-approved and JCI-accredited.
Choose Your Therapy Guide
Each guide includes mechanism, eligibility, cost breakdown, country-specific access, and clinical data.
CAR-T Cell Therapy Most Established
Read CAR-T Full GuideTIL Therapy FDA 2024
Read TIL Full GuideNK Cell Therapy Off-the-Shelf
Read NK Cell Full GuideGamma Delta T-Cells Research
Read Gamma Delta Full GuideAt-a-Glance Comparison
Key differences at a glance. Click "Learn More" for detailed analysis.
| Therapy | Best For | Key Limitation | Learn More |
|---|---|---|---|
| 🧬 CAR-T | Blood cancers (ALL, DLBCL, MM) | CRS risk, high cost in West | Learn |
| 🔬 TIL | Solid tumors (Melanoma, Cervical) | 3–5 week manufacturing time | Learn |
| 🛡️ NK Cell | Adjuvant + blood cancers | Not curative alone | Learn |
| ⚔️ Gamma Delta | Solid tumors (lung, liver, pancreas) | Research stage | Learn |
Countries Where These Therapies Are Available
Based on approval status, trial density, and cost. Explore each destination.
Are You a Referring Physician?
For clinical eligibility criteria (ECOG, prior lines of therapy), peer-to-peer case reviews, and direct trial matching.
Access Physician PortalLooking for Gene Therapy Approaches?
Beyond cellular therapies (CAR-T, TIL, NK, Gamma Delta), gene therapy approaches like tumor genetic editing (CRISPR) and cancer vaccines are also being developed.
Ready to Explore Your Options?
If you would like to be introduced to partner centers, submit an introduction request. No medical data is collected.
Explore Hospitals